P2-19-04: Changes in Adjuvant Treatment of Early Breast Cancer in Italy between 2000 and 2008. The NEMESI Study Versus the NORA Study.
Giorgio Mustacchi(University of Trieste), Davide Dondi(Sanofi (Italy)), P. Pronzato(Accademia Nazionale dei Lincei), Matteo Clavarezza(Ente Ospedaliero Ospedali Galliera), Michele Caruso(Humanitas Mater Domini), ME Cazzaniga(Casa Sollievo della Sofferenza), Paolo Bidoli(Fondazione IRCCS Istituto Nazionale dei Tumori), M. Venturini, Mastro L Del(Ospedale Antonio Cardarelli), Ferdinando Riccardi(Ospedale Antonio Cardarelli), D. Amadori(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), C. Boni(Ospedale Santa Maria)
Cited by 0
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
|New England Journal of Medicine|2014|1.1k
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
|The Lancet Oncology|2018|579